Yongzhan Nie

Title: Yongzhan Nie: Innovator in Glycosylated CEA-Specific Antibodies

Introduction

Yongzhan Nie is a prominent inventor based in Shaanxi, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer detection and therapy. His innovative work has the potential to enhance diagnostic and therapeutic strategies for tumors.

Latest Patents

Yongzhan Nie holds a patent for a "Single-chain antibody specifically binding MG7, highly glycosylated CEA and use thereof in detection and therapy." This invention provides a glycosylated CEA-specific single-chain antibody and a chimeric antigen receptor (CAR) targeting glycosylated CEA. These advancements can be utilized in the manufacture of agents or medicaments for the diagnosis or treatment of tumors that overexpress glycosylated CEA.

Career Highlights

Throughout his career, Yongzhan Nie has worked with notable institutions, including the Fourth Military Medical University in Xi'an and Shanghai Genbase Biotech Co., Ltd. His experience in these organizations has allowed him to develop his expertise in antibody research and application.

Collaborations

Yongzhan Nie has collaborated with esteemed colleagues, including Daiming Fan and Kaichun Wu. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in the field.

Conclusion

Yongzhan Nie's contributions to the field of biotechnology, particularly through his patent on glycosylated CEA-specific antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer diagnosis and therapy.